Vita Life Sciences Limited (ASX:VLS)
1.815
+0.065 (3.71%)
Apr 30, 2025, 10:50 AM AEST
Vita Life Sciences Cash Flow Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 8.78 | 9.08 | 7.08 | 8.29 | 6.09 | Upgrade
|
Depreciation & Amortization | 0.59 | 0.5 | 0.6 | 0.4 | 0.55 | Upgrade
|
Other Amortization | 0.03 | 0.02 | 0 | 0.01 | 0.01 | Upgrade
|
Asset Writedown & Restructuring Costs | - | 0.34 | - | - | - | Upgrade
|
Stock-Based Compensation | 0.44 | 0.68 | 0.71 | 0.21 | 0.09 | Upgrade
|
Provision & Write-off of Bad Debts | 0.14 | -0.01 | 0.01 | 0.01 | 0.02 | Upgrade
|
Other Operating Activities | 0.11 | -0.66 | 0.66 | -0.04 | -0.79 | Upgrade
|
Change in Accounts Receivable | -0.78 | -2.24 | -1.86 | -0.18 | 0.79 | Upgrade
|
Change in Inventory | -5.45 | 4.26 | -4.1 | -4.18 | -0.29 | Upgrade
|
Change in Accounts Payable | 2.06 | 0.99 | 0.84 | 1.63 | 0.55 | Upgrade
|
Change in Income Taxes | 0.51 | 0.04 | -0.93 | 0.07 | 0.62 | Upgrade
|
Change in Other Net Operating Assets | 0.02 | 0.16 | 0.08 | 0.04 | -0.16 | Upgrade
|
Operating Cash Flow | 6.16 | 12.98 | 2.78 | 5.89 | 7.54 | Upgrade
|
Operating Cash Flow Growth | -52.59% | 367.82% | -52.88% | -21.94% | 271.99% | Upgrade
|
Capital Expenditures | -0.2 | -0.66 | -0.14 | -0.16 | -0.09 | Upgrade
|
Investing Cash Flow | -0.2 | -0.66 | -0.14 | -0.16 | -0.09 | Upgrade
|
Long-Term Debt Repaid | -0.29 | -0.17 | -0.34 | -1.53 | -0.4 | Upgrade
|
Net Debt Issued (Repaid) | -0.29 | -0.17 | -0.34 | -1.53 | -0.4 | Upgrade
|
Issuance of Common Stock | 3.86 | 0.87 | 0.58 | 0.04 | - | Upgrade
|
Repurchase of Common Stock | -1.39 | -0.21 | -0.31 | - | -0.66 | Upgrade
|
Common Dividends Paid | -5.17 | -3.37 | -3.04 | -2.9 | -1.97 | Upgrade
|
Financing Cash Flow | -2.99 | -2.88 | -3.11 | -4.39 | -3.03 | Upgrade
|
Foreign Exchange Rate Adjustments | 1.01 | -0.51 | 0.26 | 0.07 | -0.43 | Upgrade
|
Net Cash Flow | 3.97 | 8.94 | -0.21 | 1.42 | 4 | Upgrade
|
Free Cash Flow | 5.96 | 12.32 | 2.64 | 5.73 | 7.46 | Upgrade
|
Free Cash Flow Growth | -51.66% | 367.45% | -54.03% | -23.09% | 277.66% | Upgrade
|
Free Cash Flow Margin | 7.49% | 16.78% | 3.94% | 10.04% | 16.04% | Upgrade
|
Free Cash Flow Per Share | 0.11 | 0.23 | 0.05 | 0.11 | 0.14 | Upgrade
|
Cash Interest Paid | 0.05 | 0.06 | - | - | 0.13 | Upgrade
|
Cash Income Tax Paid | 3.36 | 3.34 | 4.33 | 2.88 | 1.68 | Upgrade
|
Levered Free Cash Flow | 4.43 | 11.18 | 1.91 | 4.66 | 6.72 | Upgrade
|
Unlevered Free Cash Flow | 4.46 | 11.21 | 1.91 | 4.7 | 6.8 | Upgrade
|
Change in Net Working Capital | 3.67 | -3.26 | 5.97 | 2.65 | -1.52 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.